Among patients with non–muscle-invasive bladder cancer, neoadjuvant mitomycin demonstrated favorable safety.
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.
A woman dedicates a poem to the experience of meeting a fellow breast cancer survivor.
The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer
Melinda Bachini is the Chief Patient Officer at the Cholangiocarcinoma Foundation and a 15-year survivor of cholangiocarcinoma.
From her earliest childhood days, Tammy Allred, RN, OCN, had a vision for her future: to soothe and to heal.
The HIF-2a Inhibitor induced clinical responses among patients with von Hippel-Lindau disease–associated kidney cancer, according to results presented at the 2020 ASCO Virtual Scientific Program.
While the summer months are the perfect time for outdoor activities with friends and family, it is crucial to protect yourself from skin cancer.
Looking back in 2018, I am so glad that we sought out the other opinions. Nerve wracking as it was, the process opened up other options we would not have known about.
Here are four signs of your doctor not listening and four things I do when they don't listen to me.
Lori A. Leslie, MD, and Hoshiyuki Iida, APN, offer closing thoughts on the future treatment landscape of chronic lymphocytic leukemia.
Noelle Paul has time to talk on the way home from her job as an oncology surgical nurse at Memorial Sloan Kettering Cancer Center in New York City.
An Extraordinary Healer article honoring LAUREN H. McMURRY, B.S.N., RN [ST. JUDE CHILDREN’S RESEARCH HOSPITAL, MEMPHIS, TENNESSEE]
Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial, for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.
C. Ola Landgren provides an overview of the diagnosis and treatment of smoldering multiple myeloma.
Specialized hospital programs — with help from "The Who" rockers — support teens and young adults through cancer.
"Her goal is to improve the cancer experience and management of cancer as a chronic disease, extending those efforts into survivorship."
A partnership between the Pancreatic Cancer Action Network and Perthera, a self-described "concierge" for molecular diagnostic testing, is giving patients with this hard-to-treat cancer the ability to determine the best course of treatment.
Before closing out their discussion on differentiated thyroid cancer, patients and health care professionals alike consider unmet needs in this space.
Obesity may increase the risk of cancer recurrence. Here's what you can do to counteract it.
An Extraordinary Healer essay honoring PAM LOWRY, RN, B.S.N., CEN, OCN [MOFFITT CANCER INSTITUTE, TAMPA, FLORIDA]
What to do when treatments for side effects have their own side effects.
An Extraordinary Healer essay honoring GLORIA McBRYDE BENTON, B.S.N., RN [FORT BELVOIR COMMUNITY HOSPITAL, FORT BELVOIR, VIRGINIA]
A breast cancer survivor discusses multitasking responsibilities as a mother during cancer treatment.
An Extraordinary Healer essay honoring RENEE THOMPSON, RN, OCN [ROSWELL PARK CANCER INSTITUTE, BUFFALO, NEW YORK]